Microbiology News and Research

RSS

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

Pregnant people who are hospitalized with COVID-19 in Sub-Saharan Africa are dying at a rate far greater than pregnant people without COVID-19 and non-pregnant people with COVID-19, according to a new multicenter study encompassing six African countries.

8 Jun 2022

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm).

8 Jun 2022

Traditional methods of testing may not be enough to detect low levels of high-risk salmonella

Poultry is responsible for more than one out of every five cases of salmonella infection in the U.S. But traditional methods of testing the chicken you grab off the grocery shelf may not be enough to detect all strains of the bacteria, according to new research from the University of Georgia.

7 Jun 2022

New nanoparticles may pave the way for development of clinical sepsis therapy

Sepsis, the body's overreaction to an infection, affects more than 1.5 million people and kills at least 270,000 every year in the U.S. alone.

6 Jun 2022

MIT researchers identify components of mucus that can inhibit fungal infections

Candida albicans is a yeast that often lives in the human digestive tract and mouth, as well as urinary and reproductive organs.

6 Jun 2022

Scientists identify a new pneumococcal vaccine candidate

Researchers at Karolinska Institutet in Sweden have identified a new vaccine candidate against pneumococci, bacteria that can cause pneumonia, sepsis, and meningitis.

2 Jun 2022

Microgravity culture during spaceflight enhances microbial infection process in 3D intestinal models

Infectious microbes have evolved sophisticated means to invade host cells, outwit the body's defenses and cause disease.

1 Jun 2022

Asymptomatic COVID-19 during pregnancy could have potential long-term consequences for the baby

According to a new University of Kentucky College of Medicine study, asymptomatic COVID-19 infection during pregnancy could still have potential long-term consequences for a developing baby.

31 May 2022

Understanding transposons provides a new starting point to generate more powerful gene editing tools

CRISPR has ushered in the era of genomic medicine. A line of powerful tools has been developed from the popular CRISPR-Cas9 to cure genetic diseases.

27 May 2022

New evidence confirms that enterovirus D68 causes acute flaccid myelitis

A case report published in the New England Journal of Medicine provides evidence that enterovirus D68 directly infects spinal cord neurons and that a corresponding robust immune response is present – a direct causation to the polio-like paralyzing illness, acute flaccid myelitis (AFM).

26 May 2022

Aston University’s new antibiotic combination forms part of a lifesaving treatment for cystic fibrosis

A new antibiotic combination developed by researchers at Aston University has formed part of a lifesaving treatment used in the USA.

26 May 2022

Novavax missed its global moonshot but is angling to win over mRNA defectors

Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the small Maryland biotech startup had secured $1.6 billion in U.S. funding for its covid vaccine. Its moonshot goal: delivering 2 billion shots to the world by mid-2021.

26 May 2022

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

The accelerated advancement of cancer immunology and immunotherapy, a type of biological therapy that boosts the immune system's ability to recognize and kill cancer cells, has significantly improved the effectiveness of cancer treatment and patient outcomes.

25 May 2022

HKUMed researchers report the effects of SARS-CoV-2 on bone metabolism

A research team led by Professor Kelvin Yeung Wai-kwok and Dr Jasper Chan Fuk-woo from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that SARS-CoV-2 infection can cause inflammatory activation of bone resorption cells, leading to severe bone loss during the acute and post-recovery phases of COVID-19.

25 May 2022

Hydration restores airway integrity in people with cystic fibrosis

Cystic fibrosis is a rare genetic disease which can cause very serious symptoms. In particular, patients suffer from chronic bacterial infections that can lead to respiratory failure.

24 May 2022

UAB researchers track the behavior of microplastics inside a living organism

A UAB research team has managed to track the behavior of microplastics during their "journey" through the intestinal tract of a living organism and illustrate what happens along the way.

23 May 2022

Using microfluidics and magnets to isolate rare, allergen-reactive white blood cells

Across the world, food allergies are on the rise. One of the most important cells in studying this ailment are basophils, which activate inflammation and other responses to allergens such as rashes, and sometimes, anaphylaxis.

23 May 2022

University of Minnesota receives $66 million to establish new antiviral drug discovery center

The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.

23 May 2022

Study shows the QuickNavi-COVID19 Ag test has a high diagnostic performance for SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in nasopharyngeal samples

Researchers evaluated the diagnostic performance of a COVID-19 antigen test during the recent surge caused by the SARS-CoV-2 Omicron variant.

23 May 2022

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19.

20 May 2022

Microbiology News and Research

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

Traditional methods of testing may not be enough to detect low levels of high-risk salmonella

New nanoparticles may pave the way for development of clinical sepsis therapy

MIT researchers identify components of mucus that can inhibit fungal infections

Scientists identify a new pneumococcal vaccine candidate

Microgravity culture during spaceflight enhances microbial infection process in 3D intestinal models

Asymptomatic COVID-19 during pregnancy could have potential long-term consequences for the baby

Understanding transposons provides a new starting point to generate more powerful gene editing tools

New evidence confirms that enterovirus D68 causes acute flaccid myelitis

Aston University’s new antibiotic combination forms part of a lifesaving treatment for cystic fibrosis

Novavax missed its global moonshot but is angling to win over mRNA defectors

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

HKUMed researchers report the effects of SARS-CoV-2 on bone metabolism

Hydration restores airway integrity in people with cystic fibrosis

UAB researchers track the behavior of microplastics inside a living organism

Using microfluidics and magnets to isolate rare, allergen-reactive white blood cells

University of Minnesota receives $66 million to establish new antiviral drug discovery center

Study shows the QuickNavi-COVID19 Ag test has a high diagnostic performance for SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in nasopharyngeal samples

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

Event guide: The 10th Microbiome Movement Summit Europe 2026 eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®